In vivo testing of Biomaterials Flashcards

week 4

1
Q

What are the arguments for animal testing?

A
Mixture of cells 
EFFECTS OF VASCULATURE 
Correct body temp, fluids, pH etc.
Long term effects 
Movement included 
Can not commercialise a biomaterial without animal toxicity tests
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What must be done to do animal experiments?

A

The head of the lab needs a HOME OFFICE LICENCE 

  • EACH individual experiment is submitted to university ethics committee for approval
  • Can only do SPECIFICALLY what you set out to do in the proposal
  • Numbers of animals are STRICTLY controlled have to give statistical evidence for choice of number.
  • Need appropriate controls, Surgical/ Materials known to be non-toxic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When are project licences granted?

A

1) There is no validated alternative to animal tests 
2) There is a reasoned, sustainable justification for the generation of new test data
3) The protocols proposed cannot be further refined
4) The protocols will be likely to produce data which will meet the specified objective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How could tissue engineering contribute to replaces animal experiments?

A

Replacement 
Refinement 
Reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What needs to be tested in vivo assessment of tissue compatibility?

A

1) materials of manufacture
2) intended additives, process contaminents, residues
3) leachable substances
4) degradation products
5) other components and their interactions in the final product
6) properties and characteristics of the final product

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

During testing, why do we need to bear in mind eventual use?

A

Ie when testing material for catheter don’t need to implant it for 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the type of reactions that are tested for?

A

1) Sensitization/ Irritation/ Intracutaneous reactivity
2) Systemic toxicity (acute toxicity) Subchronic toxicity (subacute toxicity)
3) Genotoxicity
4) Implantation
5) Haemocompatibility
6) Chronic toxicity
7) Carcinogenicity
8) Reproductive and Developmental toxicity
9) Biodegradation
10) Immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the definition of blood compatibility?

A

The property of a material or device that permits it to function in contact with blood without inducing adverse reactions • Usually want to minimise clotting (exception : haemostatic device)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does BMI stand for?

A

blood materials interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is blood incompatibility?

A

BMI lead to clot or thrombus

  • may compromise device by occlusion
  • may detach (embolize) and create vessel occlusion downstream
  • susceptible devices require use of anti-coagulation drugs (heparin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is problem with using heparin?

A

anti-coagulation drug

bleeding risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are platelets?

A

non nucleated disks

250,000 cells/microlitre

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

In the absence of injury or forgein materials, what is clotting prevented by?

A

endothelial cell lining of blood vessels which exhibit heparin on their surface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does heparin consist of?

A

polysaccharides w/ SO3- and COO- charged

= provides electrostatic repulsion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How can materials trigger clotting?

A

Fibrinogen and other plasma proteins bind to exposed surface, platelets adhere to proteins

1) platelet binding triggers release of storage granule contents to extracellular environment (mediated by focal contacts)
2) granule release increases receptor expression on surface and recruits other platelets to site
3) platelet aggregation via fibrogren bridges = plug that initially reduces blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is chemotaxis?

A

cell migration along a chemical gradient

17
Q

How is blood clotted?

A

1) complex cascade of enzymatic activity on platelet surface culminates with factor X conversion of plasma protein prothrombin to thrombin
2) thrombin cleaves fibrinogen to form insoluble fibrin which crosslinks around platelet plug to form the thrombus or clot

18
Q

What are the to types of blood clotting mechanisms?

A

Extrinsic

Intrinsic

19
Q

What is the extrinsic mechanism for blood clotting?

A

1) tissue damage
2) releases tissue thromboplastin (factor III
3) activates + (Ca+2) factor VII
4) activates +(Ca+2) factor X
5) factor X + Factor V +(Ca+2)
6) activates prothrombin activator

20
Q

What is the intrinsic mechanism for blood clotting?

A

1) blood contacts foreign surface
2) activates Hageman (factor XII)
3) activates factor XI
4) activated factor IX
5) factor IX + factor VIII platelet phospholipids) + (Ca+2)
6) activates Factor X
7) activates prothrombin activator

21
Q

Where do the extrinsic and intrinsic mechanisms meet?

A

1) prothrombin activator converts prothrombin (factor II) into thrombin (factor IIa)
2) thrombin (factor IIa) converts fibrinogen (factor I) into fibrin
3) fibrin is stabilised by factor XIII to a fibrin clot

22
Q

How does the body prevent clots becoming too large?

A
  • Blood flow
  • Reaction fasted when catalysed by a surface
  • Natural inhibitors of the coagulation enzymes e.g. antithrombin iii
  • Naturally occurring enzymes break down co-factors e.g. plasmin degrades fibrin
23
Q

How can materials cause blood incompatibility?

A
  • Accumulation of thrombus forming blood agents
  • Disturbed flow
  • Embolism (clot detaches and sticks elsewhere)
  • Using up blood elements (e.g. destroying red blood cells)
24
Q

How would you modify a material to give it better blood compatibility?

A
• Coating – 
– PEO or other hydrophobic substance 
– Endothelial cells, 
– Heparin coating? GAGS? 
• Surface processing – smooth 
• Computer modelling optimise flow 
• Anti immune response
25
Q

What are the advanatages and disadvantages to in vitro tests?

A

Advantages :
+Real human blood
+Cheap, easy, reproducible
+Fast screening

Disadvantages

  • There are anticoagulants in the blood
  • Flow may not be like blood flow
  • Most surfaces would ‘pass test’
  • Dependant on how blood was collected
26
Q

What factors should be considered when sourcing blood?

A
  • species of blood donor
  • health, gender age of donor
  • blood reactivity of donor
  • time interval between blood draw
  • temperature (storage &testing)
  • drugs and anesthetics in blood
  • blood damage (centrifugation, contact with foreign surfaces, air-blood interface, pumping and recirculation)
27
Q

What are the advantages and disadvantages to animals tests?

A
Advantages 
\+Real blood flow patterns 
\+Signalling factors all present 
\+Temperature etc more consistent
\+ Device implant, use is tested

Disadvantages

  • Difficulty or interpretation
  • Not human blood
  • Anaesthetic (Or animal moves)
  • Potential need for anticoagulant
  • Local thrombus formation (don’t catch embolism)
  • Blood vessel trauma causes thrombus
28
Q

How can the results from the measure of mass of adherent thrombus be interpreted when the surface is coated with adherent thrombus?

A

1) result implying poor blood compatibility
2) many platelets adhere but the platelets are not activated and form passivating natural biological layer on the surface

29
Q

How can the results from the measure of platelet adhesion be interpreted when there are no adherent platelets?

A

1) result implying good blood compatibility

2) platelets aggregate and embolize downstream. Therefore, they are not seen on the surface

30
Q

How can the results from the measure of mass of adherent thrombus be interpreted when there are no adherent thrombus?

A

1) result implying good blood compatibility

2) thrombus detached and embolises downstream, Therefore it is not seen on the surface

31
Q

How can the results from the measure of the platelet granule release be interpreted when there are extensive platelet granule release?

A

1) result implying poor blood compatibility

2) released factors simulate desirable endothelial cell growth

32
Q

How can the results from the measure of the platelet granule release be interpreted when there are no platelet granule release?

A

1) result implying good blood compatibility
2) release actually occurs but is diluted by the flowing blood and released factor is never present in physiologically significant concentrations

33
Q

What are the advantages and disadvantages of clinical trials?

A

Advantages
+Have to test it on humans eventually

Disadvantages 
- Could cause a heart attack

34
Q

What is alkaline phosphatase (ALP)?

A
  • Converts molecules into inorganic phosphate which promotes mineralisation
  • Cells lysed to release ALP into buffer
  • Activity measured colourimetrically (colourless to yellow)
  • Total DNA quantified from same lysate
35
Q

What is Alizarin Red S (ARS)?

A

stain binds to calcium in the mineralised matrix produced by the cells

ARS solution + Ca -> Water insoluble ARS-Ca salt —(perchloric acid)—-> ARS solution

36
Q

What is direct red 80 (DR80)?

A

stain binds to collagen in the matrix produces by the cells

DR80 solution +collagen —–(sodium hydroxide and methanol——> DR80 solution